ARTICLE | Finance
ImmunoGen Inc. (IMGN)
September 11, 2000 7:00 AM UTC
Market value tracking: ImmunoGen Inc. (IMGN) ImmunoGen (IMGN) gained $4.563 (26 percent) to $21.813 on the week after Abgenix (ABGX) licensed its maytansinoid Tumor-Activated Prodrug (TAP) technology...